|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$1.47 0.00 (0.00%) as of 4:30 Thu 8/11
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
103,891,000 |
| Market
Cap: |
152.72(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.47 - $1.47 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Beveridge Roy A |
Director |
– • – |
2022-06-30 |
4 |
A |
$1.47 |
$13,124 |
D/D |
8,928 |
46,037 |
|
- |
|
| Conroy Kevin T |
Director |
– • – |
2022-06-30 |
4 |
A |
$1.47 |
$15,000 |
D/D |
10,204 |
62,318 |
|
- |
|
| Goldfischer Carl |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,994 |
22,054 |
|
- |
|
| Conroy Kevin T |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,994 |
52,114 |
|
- |
|
| Giordano Michael F |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,994 |
17,054 |
|
- |
|
| Stuckley Carol |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,994 |
25,696 |
|
- |
|
| Richon Victoria |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,994 |
22,608 |
|
- |
|
| Mott David M |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,994 |
208,332 |
|
- |
|
| Bate Kenneth |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,994 |
17,054 |
|
- |
|
| Beveridge Roy A |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,994 |
37,109 |
|
- |
|
| Kutok Jeffery |
Chief Scientific Officer |
• – – |
2022-04-11 |
4 |
AS |
$0.90 |
$2,467 |
D/D |
(2,741) |
94,563 |
|
72% |
|
| Mott David M |
Director |
– • – |
2022-03-31 |
4 |
A |
$1.15 |
$23,751 |
D/D |
20,653 |
199,338 |
|
- |
|
| Conroy Kevin T |
Director |
– • – |
2022-03-31 |
4 |
A |
$1.15 |
$14,999 |
D/D |
13,043 |
43,120 |
|
- |
|
| Beveridge Roy A |
Director |
– • – |
2022-03-31 |
4 |
A |
$1.15 |
$13,125 |
D/D |
11,413 |
28,115 |
|
- |
|
| Beaulieu Joseph |
See Remarks |
• – – |
2022-02-28 |
4 |
A |
$1.27 |
$2,952 |
D/D |
2,331 |
30,963 |
|
- |
|
| Agarwal Shefali |
See Remarks |
• – – |
2022-02-28 |
4 |
A |
$1.27 |
$2,952 |
D/D |
2,331 |
158,716 |
|
- |
|
| Beaulieu Joseph |
Corporate Controller |
• – – |
2022-02-07 |
4 |
AS |
$1.50 |
$333 |
D/D |
(222) |
28,632 |
|
-61% |
|
| Agarwal Shefali |
See Remarks |
• – – |
2022-02-07 |
4 |
AS |
$1.50 |
$1,587 |
D/D |
(1,058) |
156,385 |
|
-61% |
|
| Beaulieu Joseph |
Corporate Controller |
• – – |
2022-02-02 |
4 |
AS |
$1.37 |
$941 |
D/D |
(687) |
28,854 |
|
-52% |
|
| Agarwal Shefali |
See Remarks |
• – – |
2022-02-02 |
4 |
AS |
$1.37 |
$3,615 |
D/D |
(2,639) |
157,443 |
|
-52% |
|
| Bogle Grant C. |
See Remarks |
• • – |
2022-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
87,500 |
183,060 |
|
- |
|
| Kutok Jeffery |
Chief Scientific Officer |
• – – |
2022-02-02 |
4 |
AS |
$1.37 |
$3,502 |
D/D |
(2,556) |
97,304 |
|
-52% |
|
| Royalty Pharma Investments 2019 Icav |
Director |
– • • |
2022-01-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
22,666,667 |
|
-47% |
|
| Rpi Finance Trust |
10% Owner |
– – • |
2022-01-31 |
4 |
B |
$1.50 |
$34,000,001 |
I/I |
22,666,667 |
31,833,334 |
1.5 |
-47% |
|
| Agarwal Shefali |
See Remarks |
• – – |
2022-01-26 |
4 |
AS |
$2.02 |
$5,902 |
D/D |
(2,922) |
160,082 |
|
-72% |
|
423 Records found
|
|
Page 2 of 17 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
